https://www.sciencedaily.com/releases/2021/02/2102... Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the therapy only works for about half of all patients. Until now, there hasn't been a good way to reliably predict who will benefit and who will not.…
Check out our NEW content on how to understand breast cancer research! Understanding breast cancer research can be hard for someone who isn't a scientist. The language in research papers is very technical and complex. The point of the research may not seem clear at first glance. And you may be left wondering if the study…
http://www.cnn.com/2017/05/01/health/breast-cancer...
I wanted to reach out and see if anyone else had Mirena when diagnosed with breast cancer? I was only 30 years old when diagnosed and had Mirena put in about 1 year prior to me discovering a lump. I really think there may be a connection. I may be interested in getting together a class action suit, if there are enough of…
I started this clinical trial in May 2014 and would like to connect with anyone else who is on it. It's a Phase III trial for high risk hormone-positive, HER2- patients to see if adding one year of everolimus to hormone therapy improves disease-free survival. Anyone?